Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

AFSC

abrdn Focused U.S. Small Cap Active ETF (AFSC)

Rating:65Neutral
Price Target:$39.00▲(8.30% Upside)

AFSC, the abrdn Focused U.S. Small Cap Active ETF, has a solid overall rating, reflecting a mix of strong small-cap financial and industrial names alongside some more challenged holdings. High-quality contributors like Wintrust Financial (WTFC) and Ameris Bancorp (ABCB) support the fund with strong financial performance, positive earnings calls, and supportive technical trends, while names such as Quaker Chemical (KWR) and Magnolia Oil & Gas (MGY) face profitability, valuation, or bearish technical pressures that modestly weigh on the fund’s appeal. The main risk is that several holdings show signs of high or uncertain valuations and some sector-specific headwinds, which can increase volatility for investors.

Positive Factors
Strong Recent PerformanceThe ETF has shown strong gains so far this year and over the last few months, indicating positive recent momentum in its strategy.
Solid Top Holdings ContributionMost of the largest positions, including companies in restaurants, pharmaceuticals, software, and regional banks, have delivered strong year-to-date results that support the fund’s overall performance.
Diversified Sector Mix Within Small CapsHoldings are spread across several sectors such as health care, financials, technology, industrials, and consumer-focused companies, which helps reduce the impact of weakness in any single industry.
Negative Factors
Higher-Than-Average Expense RatioThe fund’s fee is relatively high for an ETF, which can eat into returns over time compared with lower-cost options.
Single-Country ConcentrationWith almost all assets invested in U.S. companies, the ETF offers little geographic diversification and is heavily tied to the U.S. economy.
Small-Cap and Stock-Specific RiskThe focus on U.S. small-cap stocks and meaningful weights in individual names, including at least one lagging top holding, can make the fund more volatile and sensitive to company-specific setbacks.

AFSC vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%SPY+11.99%AFSC+19.29%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
16.50M
Region
North America
Expense Ratio
0.65%
Beta
0.80
Issuer
aberdeen
Inception Date
Feb 18, 2025
Dividend Yield
0.07%
Asset Class
Equity
Index Tracked
No Underlying Index

AFSC Summary

AFSC is the abrdn Focused U.S. Small Cap Active ETF, which invests in a handpicked group of smaller U.S. companies instead of tracking a fixed index. It spreads money across areas like health care, financials, technology, and industrials, with holdings such as Brinker International and Merit Medical Systems. Investors might consider AFSC if they want growth potential from smaller, up‑and‑coming businesses and added diversification beyond large, well-known stocks. However, because it focuses on small companies and is actively managed, its price can be more volatile and can go up and down more sharply than the overall market.

How much will it cost me?

This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, with professionals selecting small-cap stocks rather than just tracking an index.

What would affect this ETF?

This ETF could benefit if the U.S. economy stays healthy, as small-cap companies in areas like health care, financials, and technology often grow faster when business activity, innovation, and consumer spending are strong, and its active managers can try to pick the most promising names. On the downside, small caps can be hit harder by economic slowdowns, rising interest rates that increase borrowing costs, or tighter financial regulations that affect regional banks and other financial holdings, and the fund’s focus on the U.S. market means it is heavily exposed to domestic economic and policy risks.

AFSC Top 10 Holdings

AFSC is leaning heavily into U.S. small-cap health care, with Kiniksa Pharmaceuticals and Ligand Pharma acting as key engines of recent gains, both riding strong momentum and upbeat fundamentals. Merit Medical Systems adds another steady health-care pillar, while Magnolia Oil & Gas gives the fund a cyclical energy kicker that’s been more mixed but still supportive. On the flip side, Supernus Pharmaceuticals is losing steam, and regional banks like Ameris Bancorp are lagging, creating a tug-of-war between high-growth medical names and more challenged financials—all firmly rooted in the U.S. market.

AFSC top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
AHRAHRAmerican Healthcare REIT, Inc.3.86%$362.53K$13.56B19.10%64Neutral
MMSIMMSIMerit Medical Systems3.34%$314.13K$5.15B2.09%68Neutral
QTWOQTWOQ2 Holdings3.30%$310.65K$4.31B0.36%75Outperform
KWRKWRQuaker Chemical3.14%$295.66K$2.66B22.09%58Neutral
SUPNSUPNSupernus3.08%$290.02K$6.07B-10.23%66Neutral
SBCFSBCFSeacoast Banking Of Florida3.02%$283.45K$3.14B10.26%62Neutral
MGYMGYMagnolia Oil & Gas2.97%$279.35K$6.19B2.42%65Neutral
OGSOGSONE Gas2.94%$276.65K$5.19B1.41%69Neutral
WTFCWTFCWintrust Financial2.88%$270.30K$10.12B19.78%78Outperform
ABCBABCBAmeris Bancorp2.85%$268.22K$5.47B13.84%78Outperform

AFSC Technical Analysis

Technical Analysis SentimentNegative
Last Price36.01

Price Trends

50DMA36.65Negative
100DMA37.54Negative
200DMA35.72Positive

Market Momentum

MACD-0.21Positive
RSI45.61Neutral
STOCH25.87Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AFSC, the sentiment is Negative. The current price of 36.01 is below the 20-day moving average (MA) of 36.38, below the 50-day MA of 36.65, and above the 200-day MA of 35.72, indicating a neutral trend. The MACD of -0.21 indicates Positive momentum. The RSI at 45.61 is Neutral, neither overbought nor oversold. The STOCH value of 25.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AFSC.

AFSC Peer Comparison

Comparison Results

AFSC against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
AFSCAFSC$36.01$39.00(8.30% Upside)$16.50M0.65%65Neutral
RUSCRUSC$35.80$51.07(42.67% Upside)$82.28M0.64%64Neutral
AIMSAIMS$26.12$34.05(30.38% Upside)$79.75M0.75%65Neutral
SYZSYZ$28.28$37.23(31.64% Upside)$60.35M0.61%66Neutral
ESSCESSC$27.83$38.17(37.13% Upside)$32.35M0.49%66Neutral
FTKIFTKI$19.30$24.51(27.00% Upside)$25.11M0.86%63Neutral

Performance Comparison

0%10%20%30%AFSCRUSCAIMSSYZESSCFTKIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AFSC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AFSCabrdn Focused U.S. Small Cap Active ETF36.016.2420.98%
RUSCUS Small Cap Equity Active ETF35.806.1720.84%
AIMSAcuitas Small Cap Active ETF26.120.943.73%
SYZLazard US Systematic Small Cap Equity ETF28.284.4218.52%
ESSCEventide Small Cap ETF27.833.1712.87%
FTKIFirst Trust Small Cap BuyWrite Income ETF19.302.6315.80%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.